AI Terminal

MODULE: AI_ANALYST

Interactive Q&A, Risk Assessment, Summarization

MODULE: DATA_EXTRACT

Excel Export, XBRL Parsing, Table Digitization

MODULE: PEER_COMP

Sector Benchmarking, Sentiment Analysis

SYSTEM ACCESS LOCKED

Authenticate / Register Log In

Medistim

Earnings Release • Oct 22, 2021

3662_rns_2021-10-22_0a10f4c1-133e-4a20-8bd0-7126236f564b.html

Earnings Release

Open in Viewer

Opens in native device viewer

Third quarter results 2021 for Medistim ASA

Sales revenues for the quarter ended at MNOK 102.1 (MNOK 83.4), an increase of 22.5%. Sales as of September ended at MNOK 309.2 (MNOK 268.9) a 15.0% increase.

Sales in the USA increased by 11.9 % in NOK. Currency neutral growth was 24.9%.

Currency neutral sales of own products increased by 33% for the quarter.

Total revenues YTD September include the Paycheck Protection Program income and reach MNOK 314.5.

Operating result (EBIT) for the quarter ended at MNOK 25.1 (MNOK 20.8) a 20.3% increase. EBIT year to date September ended at MNOK 96.8 (MNOK 73.3), a 32.0% increase. This is the best operating result YTD September ever.

Cash flow from operations YTD was a solid MNOK 81.2. Cash by the end of the quarter was MNOK 89.7.